Related references
Note: Only part of the references are listed.Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes
Juliet N. Barker et al.
BLOOD (2010)
Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation
Kenneth P. Micklethwaite et al.
BLOOD (2010)
Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects
J. Joseph Melenhorst et al.
BLOOD (2010)
Allo-HLA reactivity of virus-specific memory T cells is common
Avital L. Amir et al.
BLOOD (2010)
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes
Patrick J. Hanley et al.
BLOOD (2009)
Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors
Johannes L. Zakrzewski et al.
NATURE BIOTECHNOLOGY (2008)
Specificity of T-cell alloreactivity
Nathan J. Felix et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial
Tanzina Haque et al.
BLOOD (2007)
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals
Ann M. Leen et al.
NATURE MEDICINE (2006)
In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes
Kyung-Duk Park et al.
BLOOD (2006)
Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posarcansplantation adoptive immunotherapy
LM Serrano et al.
BLOOD (2006)
Treatment of Epstein-Barr-virus-associated primary CNS B-cell lymphoma with allogeneic T-cell immunotherapy and stem-cell transplantation
RF Wynn et al.
LANCET ONCOLOGY (2005)
Amplification of RNAi - Targeting HLA mRNAs
S Gonzalez et al.
MOLECULAR THERAPY (2005)
Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study
P Lewalle et al.
BONE MARROW TRANSPLANTATION (2003)
Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells
T Haque et al.
LANCET (2002)
Share Paper
